Pharvaris N.V. Files December 2025 6-K Report

Ticker: PHVS · Form: 6-K · Filed: Dec 3, 2025 · CIK: 1830487

Pharvaris N.V. 6-K Filing Summary
FieldDetail
CompanyPharvaris N.V. (PHVS)
Form Type6-K
Filed DateDec 3, 2025
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer, pharmaceutical

Related Tickers: PHVS

TL;DR

Pharvaris N.V. (PHVS) filed its monthly 6-K report on Dec 3, 2025. Standard update.

AI Summary

Pharvaris N.V. filed a Form 6-K on December 3, 2025, reporting for the month of December 2025. The company, previously known as Pharvaris, B.V., is a foreign private issuer incorporated in P7 and has its principal executive office in Leiden, The Netherlands. Pharvaris N.V. is listed under the SIC code 2834 for Pharmaceutical Preparations.

Why It Matters

This filing provides routine updates for Pharvaris N.V., a pharmaceutical company, which is important for investors tracking its regulatory compliance and corporate actions.

Risk Assessment

Risk Level: low — This filing is a routine, periodic report and does not contain significant new financial or operational information that would typically increase risk.

Key Players & Entities

  • Pharvaris N.V. (company) — Filer of the report
  • Pharvaris, B.V. (company) — Former company name
  • 20251203 (date) — Filing date and period of report
  • 001-40010 (other) — SEC file number
  • 2834 (other) — Standard Industrial Classification code

FAQ

What is the primary purpose of a Form 6-K filing?

A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, have filed or are required to file with a stock exchange, or have distributed or are required to distribute to their security holders.

When was Pharvaris N.V. previously known by another name?

Pharvaris N.V. was formerly known as Pharvaris, B.V., with a date of name change on October 29, 2020.

What is Pharvaris N.V.'s Standard Industrial Classification (SIC) code?

Pharvaris N.V.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Where is Pharvaris N.V.'s principal executive office located?

Pharvaris N.V.'s principal executive office is located at Emmy Noetherweg 2, 2333 BK Leiden, The Netherlands.

Does Pharvaris N.V. file annual reports under Form 20-F?

Yes, Pharvaris N.V. indicates that it files annual reports under cover of Form 20-F.

Filing Stats: 422 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2025-12-03 06:56:43

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PHARVARIS N.V. Date: December 3, 2025 By: /s/ Berndt Modig Name: Berndt Modig Title: Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.